Regenerating properties of new drug Dyalderon

The article presents studies of the functional activity of different types of immunocompetent cells in the study of regenerative properties of a new drug dyalderon. The study was performed in the laboratory, on the model of purulent wounds in male rats of the Vistar line, in accordance with internat...

Full description

Saved in:
Bibliographic Details
Main Authors: M. A. Aziamov, T. V. Agalakova
Format: Article
Language:Russian
Published: Federal Agricultural Research Center of the North-East named N.V. Rudnitsky 2017-12-01
Series:Аграрная наука Евро-Северо-Востока
Subjects:
Online Access:https://www.agronauka-sv.ru/jour/article/view/175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395778147057664
author M. A. Aziamov
T. V. Agalakova
author_facet M. A. Aziamov
T. V. Agalakova
author_sort M. A. Aziamov
collection DOAJ
description The article presents studies of the functional activity of different types of immunocompetent cells in the study of regenerative properties of a new drug dyalderon. The study was performed in the laboratory, on the model of purulent wounds in male rats of the Vistar line, in accordance with international requirements of humane treatment of laboratory animals. The two groups of rats, 10 animals each, were used to accomplish this task. Animals under anesthesia were dissected skin flap area of 20 mm2 was applied to the surface of the wound. 1bn. microbial cells of Staphylococcus aureus. Through the day the rats of the experimental group was administered with dyalderon at a dose of 30 mg intramuscularly, and the animals of the control group Cefazolin topically at a dose of 1 g per wound, during for 8 days. The criterion for the regeneration of the wounds were the time of appearance of granulation, epitelizaciei, the leukocyte count and groups T and b-lymphocytes, the level of phagocytosis and of some cytokines and decrease microbial contamination by Staphylococcus is less than 105 microbial cells per 1 cm2. Observation of the animals was carried out for 25 days. The results obtained allowed to establish that dyalderon contributed to the rapid tissue regeneration and elimination of the etiopathogenetic factors of the purulent inflammation of microbic cells, and necrotic detritus and accelerate epithelialization of wounds. This dyalderons action activated of ТН1 lymphocytes subpopulations, which stimulate the production of inflammatory cytokines а-TNF and 1-ИЛß. The maximum development of anti-inflammatory cytokines in the blood of rats of the experimental group was observed on the fifth day of а-TNF 870,8±0,24 ng/ml, 1 IL ß 29,78±0,21 ng/ml, and organism/s physiological norm, was came а-TNF 82,5±0,56 ng/ml, and IL 1 ß 16,4±0,71 ng/ml.
format Article
id doaj-art-272ee2b755934f32bf52f8e50bfac6ef
institution Kabale University
issn 2072-9081
2500-1396
language Russian
publishDate 2017-12-01
publisher Federal Agricultural Research Center of the North-East named N.V. Rudnitsky
record_format Article
series Аграрная наука Евро-Северо-Востока
spelling doaj-art-272ee2b755934f32bf52f8e50bfac6ef2025-08-20T03:39:30ZrusFederal Agricultural Research Center of the North-East named N.V. RudnitskyАграрная наука Евро-Северо-Востока2072-90812500-13962017-12-01064650174Regenerating properties of new drug DyalderonM. A. Aziamov0T. V. Agalakova1North-East Agricultural Research InstituteNorth-East Agricultural Research InstituteThe article presents studies of the functional activity of different types of immunocompetent cells in the study of regenerative properties of a new drug dyalderon. The study was performed in the laboratory, on the model of purulent wounds in male rats of the Vistar line, in accordance with international requirements of humane treatment of laboratory animals. The two groups of rats, 10 animals each, were used to accomplish this task. Animals under anesthesia were dissected skin flap area of 20 mm2 was applied to the surface of the wound. 1bn. microbial cells of Staphylococcus aureus. Through the day the rats of the experimental group was administered with dyalderon at a dose of 30 mg intramuscularly, and the animals of the control group Cefazolin topically at a dose of 1 g per wound, during for 8 days. The criterion for the regeneration of the wounds were the time of appearance of granulation, epitelizaciei, the leukocyte count and groups T and b-lymphocytes, the level of phagocytosis and of some cytokines and decrease microbial contamination by Staphylococcus is less than 105 microbial cells per 1 cm2. Observation of the animals was carried out for 25 days. The results obtained allowed to establish that dyalderon contributed to the rapid tissue regeneration and elimination of the etiopathogenetic factors of the purulent inflammation of microbic cells, and necrotic detritus and accelerate epithelialization of wounds. This dyalderons action activated of ТН1 lymphocytes subpopulations, which stimulate the production of inflammatory cytokines а-TNF and 1-ИЛß. The maximum development of anti-inflammatory cytokines in the blood of rats of the experimental group was observed on the fifth day of а-TNF 870,8±0,24 ng/ml, 1 IL ß 29,78±0,21 ng/ml, and organism/s physiological norm, was came а-TNF 82,5±0,56 ng/ml, and IL 1 ß 16,4±0,71 ng/ml.https://www.agronauka-sv.ru/jour/article/view/175granulationdyalderonimmunityratsregenerationcytokines
spellingShingle M. A. Aziamov
T. V. Agalakova
Regenerating properties of new drug Dyalderon
Аграрная наука Евро-Северо-Востока
granulation
dyalderon
immunity
rats
regeneration
cytokines
title Regenerating properties of new drug Dyalderon
title_full Regenerating properties of new drug Dyalderon
title_fullStr Regenerating properties of new drug Dyalderon
title_full_unstemmed Regenerating properties of new drug Dyalderon
title_short Regenerating properties of new drug Dyalderon
title_sort regenerating properties of new drug dyalderon
topic granulation
dyalderon
immunity
rats
regeneration
cytokines
url https://www.agronauka-sv.ru/jour/article/view/175
work_keys_str_mv AT maaziamov regeneratingpropertiesofnewdrugdyalderon
AT tvagalakova regeneratingpropertiesofnewdrugdyalderon